We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TERN market cap is 507.93M. The company's latest EPS is USD -1.0621 and P/E is -5.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -33.18M | -24.06M | -25.45M | -25.54M | -24.94M |
| Net Income | -29.77M | -21.02M | -22.37M | -22.74M | -21.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 1M | 0 | 0 |
| Operating Income | -70.2M | -37.03M | -49.86M | -62.03M | -102.56M |
| Net Income | -68.61M | -29.35M | -50.16M | -60.35M | -90.21M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 271.69M | 268.52M | 246.77M | 230.88M | 378.23M |
| Total Liabilities | 13.26M | 13.15M | 10.05M | 12.2M | 13.76M |
| Total Equity | 258.43M | 255.37M | 236.72M | 218.68M | 364.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.9M | 92.29M | 168.07M | 287.03M | 268.52M |
| Total Liabilities | 19.7M | 23.7M | 7.77M | 10.08M | 13.15M |
| Total Equity | -90.76M | -117.44M | 160.3M | 276.94M | 255.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -48.07M | -67.39M | -22.8M | -38.98M | -55.43M |
| Investing | -85.22M | -37.99M | 8M | 50.19M | 81.94M |
| Financing | 28.09M | 41.95M | N/A | 399k | 163.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -66.22M | -29.81M | -41.83M | -49.11M | -67.39M |
| Investing | -3.86M | 6.69M | -119.7M | -22.27M | -37.99M |
| Financing | 62k | 85.52M | 134.39M | 167.1M | 41.95M |
| Market Cap | 507.93M |
| Price to Earnings Ratio | -5.40 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.1 |
| Price to Book Ratio | 1.91 |
| Dividend Yield | - |
| Shares Outstanding | 84.94M |
| Average Volume (1 week) | 1.54M |
| Average Volume (1 Month) | 1.76M |
| 52 Week Change | -5.53% |
| 52 Week High | 11.40 |
| 52 Week Low | 4.32 |
| Spread (Intraday) | 1.69 (23.47%) |
| Company Name | Terns Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ternspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
